author-photo

R. Kaplan

University College London

28

Papers

631

Citations

Citation Trend

Filter By

Papers (19) Sort By

Journal Conference Others

Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models

2019 International Journal of Epidemiology
Show All
- Source
- Cite
- Save
Citations (16)
Patients' preferences for adjuvant sorafenib after resection of renal cell carcinoma in the SORCE trial: what makes it worthwhile?

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (6)
74PCommon and rare DPYD variants are predictive for 5FU/capecitabine (5FU) toxicity: The MRC COIN and COIN-B trials

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.

2018 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (20)
FOCUS4: MAMS Trial Design in Action. Early Closure of FOCUS4-D (Pan-HER 1, 2 and 3 Inhibitor Versus Placebo) in Advanced Colorectal Cancer (aCRC) Patients, with Tumours Wildtype (WT) for KRAS, NRAS, BRAF and PIK3CA

2017 The Journal of Pathology
Show All
- Source
- Cite
- Save
Citations (1)
Metformin and Cancer Risk in Type 2 Diabetes: An Application of Marginal Structural Models with Inverse Probability of Treatment Weights in the Clinical Practice Research Datalink

2016
Show All
- Source
- Cite
- Save
Citations (0)
Changing the Paradigm—Multistage Multiarm Randomized Trials and Stratified Cancer Medicine

2015 Oncologist
Show All
- Source
- Cite
- Save
Citations (19)
2105 Derived neutrophil to lymphocyte ratio as prognostic factor in patients with advanced colorectal cancer according RAS and BRAF mutations status: A post-hoc analysis of the MRC COIN study

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
2104 Derived neutrophil to lymphocyte ratio is not predictive for use of a continuous or intermittent first-line oxaliplatin/fluoropyrimidine combination in patients with advanced colorectal cancer: A post-hoc analysis of the MRC COIN study

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
The value of evidence synthesis in randomised controlled trial (RCT) design, conduct and analysis: MRC clinical trials unit (CTU) at UCL experience

2015
Show All
- Source
- Cite
- Save
Citations (0)